Antimicrobial Resistance Emerges as a Silent Pandemic, Posing a Strategic Challenge for Indian Pharmaceuticals
Antimicrobial resistance (AMR) is fast becoming one of the most serious threats to modern medicine, with new global evidence showing […]
Pharma
Multistage Malaria Vaccine Trial Signals New Opportunity for Next-Gen Immunisation Research
New hope for malaria-endemic regions as ProC6C vaccine demonstrates 76% efficacy in clinical trial. A novel multistage malaria vaccine, ‘ProC6C-AlOH/MM’ […]
FDA Clears Oral Version of Wegovy, Expanding Access to GLP-1 Obesity Treatments
Novo Nordisk’s daily semaglutide tablet offers an alternative to injectables as competition intensifies in the weight-loss drug market The US […]
India Introduces Minimum Import Price on Key Pharma Inputs to Strengthen Domestic Manufacturing
Policy aims to counter import dumping, enhance supply-chain security, and accelerate API self-reliance The Union Government has introduced a minimum […]
Early-Stage Nipah Virus Vaccine Trials Signal Progress in Pandemic Preparedness
Phase I results and launch of world’s first Phase II trial strengthen global efforts against a high-fatality zoonotic threat Early […]
NutriGPT: AI-Engine Enabling On-Demand, Regulatory-Ready Formulation Design for Global Pharma
A breakthrough AI tool enabling SMEs to create validated, regulatory-compliant nutraceutical formulations with enterprise-level precision. Nutrify Today, the world’s largest […]
Zydus Unveils ‘Zyrifa’: A Strategic Biosimilar that Targets Bone Health in Oncology Patients
Zydus Lifesciences Ltd., an innovation-driven global healthcare company, has announced the launch of ‘Zyrifa’, its biosimilar version of Denosumab 120 […]
Zydus, Formycon Collaborate to Bring Keytruda® Biosimilar to the US and Canada
Zydus Lifesciences has entered the North American biosimilar market with a major strategic move, announcing an exclusive partnership with Germany-based […]
AIM-NASH: First-Ever Digital Pathology Tool Approved by FDA for Liver Drug Trials
A major milestone for AI-driven drug development, the U.S. Food and Drug Administration (FDA) has officially qualified AIM-NASH, the first […]
Dr. Reddy’s Inks Licensing Deal Worth Up to $370M for Immutep’s Late-Stage Eftilagimod Alpha
Strengthening its oncology innovation portfolio, Dr. Reddy’s Laboratories has entered into an exclusive licensing agreement with Australian biotech Immutep to […]
Jammu & Kashmir Sets the Stage for a ₹1000-Crore MAP Value Chain: A New Frontier for Pharma & Nutraceuticals
The Jammu and Kashmir administration is accelerating its push to transform the Union Territory into a leading hub for medicinal […]
Strengthening Global Pharma Influence: EU’s Critical Medicines Act Becomes a Strategic Opening for India
As Europe accelerates efforts to fortify its pharmaceutical supply chain, the proposed Critical Medicines Act (CMA) is emerging as a […]
Modi–Putin Talks Poised to Accelerate Bilateral Pharma Innovation
The upcoming meeting between India’s Prime Minister Narendra Modi and Russian President Vladimir Putin is expected to deliver significant momentum […]
